Skip to content. | Skip to navigation

Personal tools


Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1

Secondary managing bodies

logo ENSL logo ucb1

You are here: Home

Search results

44 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
Kick-off of the industrial chair VIRESP
On Wednesday January 24, 2024, Université Claude Bernard Lyon 1 (UCBL), Hospices Civils de Lyon (HCL) (HCL), the French National Research Agency (ANR) and Sanofi officially launched the the VIRESP industrial chair, a research project focusing on the development of techniques and tools for analyzing the risk of infection and the morbidity rate of diseases in different populations, but also to determine the benefits of vaccination programs.
Located in About us / News
Antibiotic resistance: How some bacteria acquire resistance genes from their environment?
Antibiotic resistance has made certain infections, sometimes common, such as urinary and respiratory infections, impossible to treat, representing a major setback in the medical care of human and animal patients. This resistance has thus become a major health issue, which has led the WHO (World Health Organization) to establish a list of bacteria in which antibiotic resistance is particularly worrying.In a new study published in the journal mBio, we focused on one of these bacteria that are particularly resistant to antibiotics, Acinetobacter baumannii. The latter is responsible for many opportunistic and nosocomial infections. We have determined the mechanisms that allow this bacterium to rapidly acquire resistance genes from neighboring bacteria.
Located in Teams / Charpentier X - Horigene / News
COVID-19: Multisystem Inflammatory Syndrome in Children existed before the pandemic
During the COVID-19 pandemic, multisystemic inflammatory syndrome affected 1,100 children. Since this first description in 2020, CIRI researchers, HCL clinicians and other international collaborators have discovered that this syndrome existed before COVID-19, and that other infectious agents could lead to this severe inflammatory syndrome in children. These findings are published in the New England Journal of Medicine.
Located in Teams / Walzer T - LYACTS / Actualités
Autophagy, a key role in the pathophysiology of Crohn's disease
In a new study published in the journal Autophagy, CIRI researchers have shown for the first time that, in patients with Crohn's disease, the expression of autophagic gene variants strongly affects autophagic dynamics, known as autophagic flux.
Located in About us / News
Impact of vaccination on induction of mucosal immunity with mRNA vaccines against Covid-19 epidemic.
Teams from the Immunology Department of the Pitié-Salpêtrière AP-HP hospital, Inserm and Sorbonne University, coordinated by Prof. Guy Gorochov, have conducted a study on the ability of Covid-19 mRNA vaccines to induce a mucosal immune response. CIRI members took part in this study. The results were published in JAMA Network Open on April 23, 2024.
Located in About us / News
Launch of the Chaire industrielle REVIDA
On october 11, the Chaire industrielle REVIDA about respiratory infectious diseases, led by the researcher Sophie Trouillet-Assant (UCBL/HCL), was officially launched by the Université Claude Bernard Lyon 1, the Hospices Civils de Lyon, and bioMérieux, with the support of the Agence nationale de la recherche. It should enable the improvement of the capacity of health systems to face the emerging of new respiratory diseases.
Located in About us / News
HERVCOV: A european project coordinated by Branka Horvat
The protein that opens doors to the medicine of the future and treatment of COVID-19
Located in Teams / Horvat B - IbIV / Actualités
Recent books published by members of the CIRI
Members of the CIRI contributed to two books that were recently published. One is about the history of microbiology, and the other tackles research progress linked to the COVID-19 pandemic.
Located in About us / News
CERP/PHE3ID team awarded the Shapemed@Lyon call "Projets d'amorçage"
The PHE3ID/CERP research team has been awarded with one of the first Projets d’Amorçage supported by SHAPE-Med@Lyon
Located in CERP
Rare Disease Day 2024
February 29, 2024 is Rare Disease Day. This is an opportunity to thank the clinicians and researchers who are advancing research on this subject at CIRI, as well as our patients!
Located in About us / News